Capabilities and limitations of major drug groups in allergy: their role within current theories.
D000109:Acetylcholine / Q000494:pharmacology; D000941:Antigens; D001920:Bradykinin / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003877:Dermatitis, Contact / Q000188:drug therapy; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D005938:Glucocorticoids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy* / Q000276:immunology; D008407:Mast Cells / Q000187:drug effects / Q000502:physiology; D011955:Receptors, Drug / Q000502:physiology; D012130:Respiratory Hypersensitivity / Q000188:drug therapy; D012701:Serotonin / Q000494:pharmacology; D013566:Sympathomimetics / Q000627:therapeutic use*
D000941:Antigens; D002395:Catecholamines; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D011955:Receptors, Drug; D013566:Sympathomimetics; D012701:Serotonin; D006632:Histamine; D006493:Heparin; D000109:Acetylcholine; D001920:Bradykinin; D004837:Epinephrine